⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 4, 2021HepatologyOpen Access

BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial

Eric Lawitz Diane E. Shevell Giridhar Tirucherai Shuyan Du Warner Chen Uma Kavita Angie Coste Fred Poordad M.A. Karsdal Mette Juul Nielsen Zachary Goodman Edgar D. Charles

View Full Paper

Ask AI

Bookmark

Share

Abstract

In patients with HCV-SVR, BMS-986263 administration was generally well tolerated through Week 36 and resulted in METAVIR and Ishak score improvements. Further evaluation of BMS-986263 in patients with active fibrogenesis is warranted.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lawitz et al. (2021) studied this question.

synapsesocial.com/papers/69d9a63ba1d151c65f684bd3 https://doi.org/10.1002/hep.32181

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment conceptsClinical Guideline · 2018 · 104 citations
2Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysisMeta-Analysis · 2017 · 1,957 citations
3All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C VirusCohort Study · 2015 · 71 citations
4Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patientsRetrospective Study · 2017 · 38 citations
5Collagen biology and non‐invasive biomarkers of liver fibrosisReview · 2020 · 199 citations

More related papers

Roles of the endoplasmic reticulum–resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease2018
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats2004
Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis.1994

More from Hepatology

AASLD AGA clinical Practice Guideline on management of primary biliary cholangitisThu,
Saroglitazar improves hepatic steatosis and liver enzymes in women with polycystic ovary syndrome and MASLD: A multicenter, double-blind, placebo-controlled studyThu,